Skip to main content

Advertisement

SpringerLink
Log in

Mucosal Melanoma: a Literature Review

  • Melanoma (RJ Sullivan, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Mucosal melanoma is of great interest due to its aggressive behavior and less favorable prognosis. The literature is mainly case reports and case series. Here, we will collect the knowledge on mucosal melanoma from the last decade and review the literature. The main focus is being site-specific clinical features, treatment, and prognosis.

Recent findings

The use of immunotherapy gain ground as for others subsets of melanoma. Anti-CTLA-4 and anti-PD-1/ PD-L1 blockade in mucosal melanoma have been evaluated in recent studies. Clinical trials are ongoing.

Summary

The etiology of mucosal melanomas remains unknown. Head and neck mucosal melanomas are most common. Wide excision surgery is the treatment of choice. The effect of adjuvant therapy on survival remains questionable due to the limited knowledge. Radiotherapy seems to give better local control. The overall five-year survival rate for mucosal melanomas is 0–45%. Recent data indicates that this may be improved by the immunotherapy in the years to come.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. López F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall WM, et al. Update on primary head and neck mucosal melanoma. Head & Neck, 2016, 38.1: 147-155.

  2. Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas : a comprehensive review. Int J Clin Exp Pathol. 2012;5:739–53.

    PubMed  PubMed Central  Google Scholar 

  3. Spencer KR, Mehnert JM. Mucosal melanoma : epidemiology, biology and treatment. Melanoma, Cancer Treat Res. 2016;167:295–320.

    Article  PubMed  Google Scholar 

  4. Postow MA, Hamid O, Carvajal RD. Mucosal melanoma : pathogenesis, clinical behavior, and management. Curr Oncol Rep. 2012;14:441–8.

    Article  CAS  PubMed  Google Scholar 

  5. Moreno MA, Hanna EY. Management of mucosal melanomas of the head and neck : did we make any progress? Curr Opin Otolaryngol Head Neck Surg. 2010;18(2):101–6.

    Article  PubMed  Google Scholar 

  6. Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermathology. 2007;56:828–34.

    Article  Google Scholar 

  7. Seetharamu N, Ott PA, Pavlick AC. Mucosal melanomas: a case-based review of the literature. Oncologist. 2010;15:772–81.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, et al. Update on primary mucosal melanoma. J Am Dermatology. 2014;71:366–75.

  9. Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, et al. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. Eur J Cancer. 2016;65:156–63.

  10. Itoh M, Goto A, Wakasugi H, Yoshida Y, Matsunaga Y, Fujii K, et al. Anorectal melanoma with a KIT-activating mutation, which is a target for tyrosine kinase inhibitor. Int J Clin Oncol. 2011;16:428–34.

  11. • Angelo SPD, Larkin J, Sosman JA, Lebb C, Brady B, Neyns B, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma : a pooled analysis. J Clin Oncol. 2017;35:226–35. For mucosal melanoms, nivolumab combined with ipilimumab seemed to have greater efficacy than either agent alone. However, the incidence of grades 3 or 4 treatment-related adverse events was 40.0% for combination therapy. Patient selection is of great importance.

    PubMed  Google Scholar 

  12. Boulaadas M, Benazzou S, Mourtada F, Sefiani S, Nazih N, Essakalli L, et al. Primary oral malignant melanoma. J og craniofacial Surg. 2007;18:1059–61.

  13. Auluck A, Zhang L, Path DO, Frcd C. Primary malignant melanoma of maxillary gingiva —a case report and review of the literature. Clin Pract. 2008;74:367–71.

    Google Scholar 

  14. Kumar SKS, Shuler CF, Sedghizadeh PP, Kalmar JR. Oral mucosal melanoma with unusual clinicopathologic features. J Cutan Pathol. 2008;35:392–7.

    Article  PubMed  Google Scholar 

  15. Tsutsumida A, Yamamoto Y, Sekido M, Itoh T. Suspected case of primary malignant melanoma of the parotid gland. Scand J Plast Reconstr Surg Hand Surg. 2008;42:105–7.

    Article  PubMed  Google Scholar 

  16. Godoy GP, de Castro Gomes DQ, Pereira JV, de Queiroz Figueiredo RL, Nonaka CFW, da Costa Miguel MC. Desmoplastic melanoma of the lower lip: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2009;108:e64–9.

    Article  Google Scholar 

  17. Umeda M, Murata M, Suzuki H, Yanagida T, Shibuya Y, Komori T. A case of malignant melanoma of the oral cavity alive with liver metastasis for a long period with administration of a biologic response modifier, OK432. Kobe J Med Sci. 2010;56:140–7.

    Google Scholar 

  18. Reddy B, Sridhar GR, Anuradha CH, Chandrasekhar P, Lingamaneni KP. Malignant melanoma of the mandibular gingiva: a rare occurrence. Indian J Dent Res. 2010;21:302–5.

    Article  CAS  PubMed  Google Scholar 

  19. Demirdöver C, Sahin B, Ozkan HS, Oztan HY. Malignant melanoma of the lower lip: case report. J Plast Reconstr Aesthet Surg. 2010;63:e298–9.

    Article  PubMed  Google Scholar 

  20. Beier US, Salinas T, Puelacher W. Resection of a primary oral malignant melanoma and rehabilitative management using nasolabial flap: a case report. Oral Maxillofac Surg. 2012;16:141–5.

    Article  PubMed  Google Scholar 

  21. Ahmadi-Motamayel F, Falsafi P, Baghaei F. Report of a rare and aggressive case of oral malignant melanoma. Oral Maxillofac Surg. 2013;17:47–51.

    Article  PubMed  Google Scholar 

  22. Mohan M, Sukhadia VY, Pai D, Bhat S. Oral malignant melanoma: systematic review of literature and report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Elsevier. 2013;116:e247–54.

    Article  Google Scholar 

  23. Mostafa MG, Hussein MR, El-Ghorory RM, Gadullah HA. Gastric metastases from invasive primary mucosal epithelioid malignant melanoma of the hard palate: report of the first case in the English literature. Expert Rev Gastroenterol Hepatol. 2014;8:15–9.

    Article  CAS  PubMed  Google Scholar 

  24. Lamichhane NS, An J, Liu Q, Zhang W. Primary malignant mucosal melanoma of the upper lip: a case report and review of the literature. BMC Res Notes. 2015;8:499.

    Article  PubMed  Google Scholar 

  25. Tlholoe MM, Khammissa RAG, Bouckaert M, Altini M, Lemmer J, Feller L. Oral mucosal melanoma: some pathobiological considerations and an illustrative report of a case. Head Neck Pathol. 2015;9:127–34.

    Article  CAS  PubMed  Google Scholar 

  26. Ali EAM, Karrar MA, El-Siddig AA, Zulfo A. Oral malignant melanoma: a rare case with unusual clinical presentation. Pan Afr Med J. 2015;22:113.

    PubMed  PubMed Central  Google Scholar 

  27. Wushou A, Zhao Y. The management and site-specific prognostic factors of primary oral mucosal malignant melanoma. J Craniofac Surg. 2015;26:430–4.

    Article  PubMed  Google Scholar 

  28. Mısır AF, Durmuşlar M, Zerener T, Gün B. Primary malignant melanoma. Saudi Med J. 2016;37:446–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lourenço SV, Fernandes JD, Hsieh R, Coutinho-camillo CM, Bologna S, Sangueza M, et al. Head and neck mucosal melanoma : a review. Am J Dermatopathol. 2014;36:578–87.

    Article  PubMed  Google Scholar 

  30. Wu C-F, Wu C-S, Yu W-W, Huang M-Y. Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy. Head Neck. 2015;37:E134–8.

    Article  PubMed  Google Scholar 

  31. Wushou A, Hou J, Zhao Y, Miao X. Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma. J Cranio-Maxillofacial Surg. 2015;43:553–8.

    Article  Google Scholar 

  32. Pathma L, Philip R, Harvinder S, Manjit S. Sinonasal malignant melanocytic melanoma: a rare case report. Med J Malaysia. 2008;63:152–3.

    CAS  PubMed  Google Scholar 

  33. Baptista P, Velloso MJG, Salvinelli F, Casale M. Radioguided surgical strategy in mucosal melanoma of the nasal cavity. Clin Nucl Med. 2008;33:14–8.

    Article  PubMed  Google Scholar 

  34. Norhafizah M, Mustafa WM, Sabariah AR, Shiran MS, Pathmanathan R. Mucosal malignant melanoma of the maxillary sinus. Med J Malaysia. 2010;65:218–20.

    CAS  PubMed  Google Scholar 

  35. Kobayashi S, Nakajima T, Iizasa T, Tsujimura H, Itami M, Kimura H. Pulmonary metastasis with endobronchial spread from sinonasal melanoma during a 9-year follow-up. Intern Med. 2010;49:777–9.

    Article  PubMed  Google Scholar 

  36. González-García R, Ruiz-Laza L, Román-Romero L. Lateral rhinotomy combined with anterior transantral approach for the treatment of large malignant melanoma of the nasal cavity involving the nasopharynx. J Cranio-Maxillo-Facial Surgery-Facial Surg. 2012;40:266–70.

    Article  Google Scholar 

  37. Ozyigit G, Cengiz M, Yazici G, Yildiz F, Sezen D, Yildiz D, et al. Robotic stereotactic body radiotherapy in the treatment of sinonasal mucosal melanoma: report og four cases. Head Neck. 2011;35:E69–73.

    Article  PubMed  Google Scholar 

  38. Smith SM, Schmitt AC, Carrau RL, Iwenofu OH. Primary sinonasal mucosal melanoma with aberrant diffuse and strong desmin reactivity: a potential diagnostic pitfall! Head Neck Pathol. 2015;9:165–71.

    Article  PubMed  Google Scholar 

  39. Rapisuwon S, Parks K, Al-Refaie W, Atkins MB. Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report. Melanoma Res. 2014;24:509–11.

    Article  PubMed  Google Scholar 

  40. Bourgeois DJ, Singh AK. Single-fraction steretactic body radiation therapy for sinonasal malignant melanoma. Head Neck. 2015;37:E34–7.

    Article  PubMed  Google Scholar 

  41. Clifton N, Harrison L, Bradley PJ, Jones NS. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol. 2011;125:479–85.

    Article  CAS  PubMed  Google Scholar 

  42. Mochel MC, Duncan LM, Piris A, Kraft S. Primary mucosal melanoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of thirty-two cases. Head Neck Pathol Springer US. 2015;9:236–43.

    Article  Google Scholar 

  43. Moore A. The role of radiotherapy in the management of sinonasal melanoma and its impact on patients and healthcare professionals. Eur Arch Otorhinolaryngol. 2014;271:3021–6.

    Article  CAS  PubMed  Google Scholar 

  44. Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, De BR, et al. The role of systemic therapy in the management of sinonasal cancer : a critical review. Cancer Treat Rev Elsevier Ltd. 2015;41:836–43.

    Article  CAS  Google Scholar 

  45. Shikuma K, Omasa M, Yutaka Y, Okuda M, Taki T. Treatment of primary melanoma of the lung monitored by 5-S-cysteinyldopa levels. Ann Thorac Surg. 2009;87:1264–6.

    Article  PubMed  Google Scholar 

  46. Mcnab P, Quigley B, Mendoza T, Hakam A, Khalil F, Case Report FM. The histogenic origin of melanoma arising in respiratory epithelium of a teratomatous germ cell tumor of the mediastinum : an enigma unraveled from an unlikely source. Int J Clin Exp Pathol. 2011;5:982–90.

    Google Scholar 

  47. Gong L, Liu X, Zhang W, Zhu S, Yao L, Han X, et al. Primary pulmonary malignant melanoma: a clinicopathologic study of two cases. Diagn Pathol. 2012;7:123.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Taniguchi T, Kawaguchi K. Primary malignant melanoma of the thymus: report of a case. Surg Today. 2015;45(9):1187–9.

    Article  PubMed  Google Scholar 

  49. Aggarwal S, Kaushal V, Singla S, Sen R. Primary glottic malignant melanoma of the larynx (PGMML): a very rare entity. BMJ Case Rep. 2015:1–4.

  50. Heyn J, Placzek M, Ozimek A, Baumgaertner AK, Siebeck M, Volkenandt M. Malignant melanoma of the anal region. Clin Exp Dermatol. 2007;32:603–7.

    Article  CAS  PubMed  Google Scholar 

  51. Kenney B, Dotto J, Homer R, Shafi N, Davydova L. Primary malignant melanoma of the transverse colon: reports of a case and review of the literature. Int J Surg Pathol. 2007;15:401–7.

    Article  PubMed  Google Scholar 

  52. Karmiris K, Roussomoustakaki M, Tzardi M, Romanos J, Grammatikakis J, Papadakis M, et al. Ileal malignant melanoma causing intussusception: report of a case. Surg Today. 2007;37:506–9.

  53. Gong L, Li Y-H, Zhao J-Y, Wang X-X, Zhu S-J, Zhang W. Primary malignant melanoma of the liver: a case report. World J Gastroenterol. 2008;14:4968–71.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Satzger I, Küttler U, Völker B, Schenck F, Kapp A, Gutzmer R. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy—case report and review of the literature. Dermatology. 2009;220:77–81.

    Article  PubMed  Google Scholar 

  55. Yang JI, Byun HJ, Kang JM. Gastrointestinal: anorectal malignant melanoma. J Gastroenterol Hepatol. 2009;24:697.

    Article  CAS  PubMed  Google Scholar 

  56. Katsourakis A, Noussios G, Alatsakis M, Chatzis I, Chatzitheoklitos E. Primary malignant melanoma of the small intestine: a case report. Acta Chir Belg. 2009;109:405–7.

    Article  CAS  PubMed  Google Scholar 

  57. Doǧan M, Özdemir S, Geçim E, Erden E, Içli F. Intestinal malignant melanoma presenting with small bowel invagination: a case report. Turkish J Gastroenterol. 2010;21:439–42.

    Article  Google Scholar 

  58. Minami H, Inoue H, Satodate H, Hamatani S, Shin-Ei K. A case of primary malignant melanoma in situ in the esophagus. Gastrointest Endosc. 2011;73:814–5.

    Article  PubMed  Google Scholar 

  59. Casey S, Dvorkin L, Alsanjari N, Dezso B. Symptomatic malignant melanoma presenting as multiple gastrointestinal polyps. BMJ Case Rep 2011;bcr0320102866.

  60. Kottchade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, et al. Rare presentations of primary melanoma and special populations. Am J Clin Oncol. 2014;37:635–41.

    Article  Google Scholar 

  61. Yamamoto S, Makuuchi H, Kumaki N, Ozawa S, Shimada H, Chino O, et al. A long surviving case of multiple early stage primary malignant melanoma of the esophagus and a review of the literature. Tokai J Exp Clin Med. 2015;40:90–5.

  62. Machado J, Ministro P, Araújo R, Cancela E, Castanheira A, Silva A. Primary malignant melanoma of the esophagus: a case report. World J Gastroenterol. 2011;17:4734–8.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Prosvicova J, Lukesova S, Kopecky J, Grim J, Papik Z, Kolarova R, et al. Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: a case report. Biomed Pap. 2015;159:695–7.

    Google Scholar 

  64. Song W, Liu F, Wang S, Shi H, He W, He Y. Primary gastric malignant melanoma: Challenge in preoperative diagnosis. Int J Clin Exp Pathol. 2014;7:6826–31.

    PubMed  PubMed Central  Google Scholar 

  65. Cubukcu E, Olmez OF, Ozkan K, Pekgoz M, Ugras N, Deligonul A, et al. Malignant melanoma of the stomach in an elderly patient. Turkish. J Gastroenterol. 2014;25:295–6.

    Google Scholar 

  66. Yoshizawa T, Kawata N, Sato K, Hirakata H, Igarashi T, Ichinose T, et al. Primary malignant melanoma of the female urethra. Urology. 2007;70:1222.e13–6.

    Article  Google Scholar 

  67. McGuire SE, Frank SJ, Eifel PJ. Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy. Brachytherapy. 2008;7:359–63.

    Article  PubMed  Google Scholar 

  68. Grenader T, Isacson R, Reinus C, Rosengarten O, Barenholz O, Hyman J, et al. Primary amelanotic melanoma of the vagina. Oncol Res Treat. 2008;31:474–6.

    Google Scholar 

  69. Baderca F, Cojocaru S, Lazǎr E, Lǎzureanu C, Lighezan R, Alexa A, et al. Amelanotic vulvar melanoma: case report and review of the literature. Romanian J Morphol Embryol. 2008;49:219–28.

    Google Scholar 

  70. Gungor T, Altinkaya SO, Ozat M, Bayramoglu H, Mollamahmutoglu L. Primary malignant melanoma of the female genital tract. Taiwan J Obstet Gynecol. 2009;48:169–75.

    Article  PubMed  Google Scholar 

  71. Pusceddu S, Bajetta E, Buzzoni R, Carcangiu ML, Platania M, Del Vecchio M, et al. Primary uterine cervix melanoma resembling malignant peripheral nerve sheath tumor: a case report. Int J Gynecol Pathol. 2008;27:596–600.

    Article  PubMed  Google Scholar 

  72. Te LL, Bin LC, Chen SN, Chiang AJ, Liou WS, Yu KJ. Primary malignant melanoma of the vagina with repeated local recurrences and brain metastasis. J Chinese Med Assoc. 2011;74:376–9.

    Article  Google Scholar 

  73. Pandey PK, Vijay MK, Goel H, Shukla S. Primary malignant melanoma of the female urethra: a rare neoplasm. J Cancer Res Ther. 2014;10:758–60.

    PubMed  Google Scholar 

  74. Filippetti R, Pitocco R. Amelanotic vulvar melanoma : a case report. Am J Dermatopathol. 2015;37:e75–7.

    Article  PubMed  Google Scholar 

  75. Das P, Kumar N, Ahujs A, Jain A, Ray R, Sarkar C, et al. Primary malignant melanoma at unusual sites: an institutional experience with review of literature. Melanoma Res. 2010;20:233–9.

    PubMed  Google Scholar 

  76. Maeda Y, Ito F, Nakazawa H, Tomoe H, Aiba M, Tanabe K. Penile malignant melanoma in a hemodialysis patient. Int J Urol. 2008;15:741–3.

    Article  PubMed  Google Scholar 

  77. Te CC, Vemulapalli S, Confer SD, Culkin DJ. Recurrent malignant melanoma of the penis. Urology. 2008;72:1185.e15–6.

    Article  Google Scholar 

  78. Dogu GG, Yaren A, Tuncay L, Senturk N, Zumrutbas AE, Taskoylu BY, et al. Primary malignant melanoma of the penis: a case report. Med Oncol. 2012;29(2):1300–3.

  79. McLoughlin LC, Davis NF, Cham A, Mohan P. Primary penile melanoma with an incidental renal oncocytoma. BMJ Case Rep. 2013:1–3.

  80. Li Y, Yuan H, Wang A, Zhang Z, Wu J, Wei Q. Malignant melanoma of the penis and urethra: one case report. World J Surg Oncol. 2014;12:340.

    Article  PubMed  PubMed Central  Google Scholar 

  81. van Geel AN, den Bakker MA, Kirkels W, Horenblas S, Kroon BBR, de Wilt JHW, et al. Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology. 2007;70:143–7.

  82. Wollina U, Steinbach F, Verma S, Tchernev G. Penile tumours : a review. J Eur Acad Dermatol Venereol. 2014;28:1267–76.

    Article  CAS  PubMed  Google Scholar 

  83. Bartell HL, Bedikian AY, Papadopoulos NE, Dett TK, Ballo MT, Myers JN, et al. Biochemotherapy in patients with advanced head and neck mucosal melanoma. Head Neck. 2008;30:1592–8.

  84. Postow MA, Luke JJ, Bluth MJ, Parangeas KS, Lawrence DP, Ibrahim N, et al. Ipilimumab for patients with advanced mucosal melanoma. Oncologist. 2013;18:726–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, et al. Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma. Cancer Immunol Immunother. 2014;63:675–83.

  86. • Ascierto PA, Vanella V, Maria A, Festino G, Palla M, Simeone E, et al. Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase : a case report from a phase III trial. Cancer Immunol Immunother. 2016;65:1395–400. A case from a phase III trail (CheckMate 066) who achieved a partial response to dacarbazine, followed by a durable complete response with nivolumab monotherapy treatment. The outcome of the complete trail is of great interest.

    Article  CAS  PubMed  Google Scholar 

  87. • Shoushtari AN, Munhoz RR, Kuk D, Ott PA, Johnson DB, Tsai KK, et al. The efficacy of Anti-PD-1 agents in acral and mucosal melanoma. Cancer. 2016;122:3354–62. This multi-institutional, retrospective cohort analysis identifies response rates to PD-1 blockade comparable to the published rates in patients with cutaneous melanoma and support the routine use of PD-1 blockade in clinical practice for mucosal melanomas.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Plastic Surgical Research Unit, Department of Plastic Surgery, Aarhus University Hospital, Noerrebrogade 44, 8000, Aarhus C, Denmark

    Simon Skovsted Yde, Pia Sjoegren, Martin Heje & Lars B. Stolle

Authors
  1. Simon Skovsted Yde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pia Sjoegren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Heje
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lars B. Stolle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Skovsted Yde.

Ethics declarations

Conflict of Interest

Simon Skovsted Yde, Pia Sjoegren, Martin Heje, and Lars B. Stolle declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Melanoma

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yde, S.S., Sjoegren, P., Heje, M. et al. Mucosal Melanoma: a Literature Review. Curr Oncol Rep 20, 28 (2018). https://doi.org/10.1007/s11912-018-0675-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11912-018-0675-0

Keywords

Search

Navigation